New vs. standard robotic prostate surgery for early cancer
Part of Cancer, Kidney & urinary clinical trials.
This study compares two ways of doing robot‑assisted prostate removal surgery. It aims to see if a newer, less invasive method through a single small cut is as safe and effective as the standard method. If you have early‑stage prostate cancer and are eligible, you could help improve surgical recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 75 years old.
- Your prostate cancer has not spread outside the prostate (stage T1c to T2b, N0, M0).
- Your Gleason score is less than 8 and PSA level is under 20 ng/mL.
- You have a common type of prostate cancer (adenocarcinoma) and are able to have intercourse both before and after surgery.
- You are in good enough health for a laparoscopic surgery and can fill out questionnaires in Chinese.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new imaging technique (PSMA-PET/MRI fused with ultrasound) helps surgeons perform more precise robotic prostate removal in men with prostate cancer that has started to spread outside the gland. It aims to improve cancer control and reduce side effects.
This trial compares two nerve-sparing techniques during robotic prostatectomy to see which better preserves urinary and sexual function while still effectively removing the cancer. It is for men with early-stage, favorable-risk prostate cancer who are good surgical candidates.
This trial compares a new robotic surgical technique (with a special urethra repair) to standard robotic surgery and laparoscopic surgery for men with newly diagnosed prostate cancer that has not spread. The goal is to see which approach best preserves urinary control.
This study compares two robotic surgery approaches for prostate and kidney cancer—one using a single small incision versus multiple small incisions. The goal is to see if one method works better, is safer, or helps patients recover faster.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial tests whether adding a 3D augmented-reality model to standard robot-assisted prostate surgery can help doctors remove the cancer while better preserving sexual function. It is for men whose MRI shows the cancer may have slightly spread outside the prostate.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.